Skip to main content
Clinical Trials/NCT03473080
NCT03473080
Completed
N/A

Feasibility of a Therapist and Parent Guided eHealth Intervention for Obsessive Compulsive Disorder in Youth With Autism Spectrum Disorder

Karolinska Institutet1 site in 1 country22 target enrollmentMarch 9, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Obsessive-Compulsive Disorder
Sponsor
Karolinska Institutet
Enrollment
22
Locations
1
Primary Endpoint
Children's Yale-Brown Obsessive Compulsive Scale
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study is a feasibility study of Internet-delivered CBT for OCD in children and adolescents (7-17 years) with comorbid Autism Spectrum Disorder.

Detailed Description

The main objectives of this study is to evaluate the feasibility, acceptability and preliminary efficacy of internet-delivered Cognitive Behavioral Therapy (ICBT) for Obsessive Compulsive Disorder (OCD) in children and adolescents (7-17 years) with Autism Spectrum Disorders (ASD). The study will an open trial with-in group mean comparison design (n=18). The treatment is delivered over 16 weeks. Study participants will be followed up at 3 (primary endpoint), 6 and 12 months after completed treatment. ICBT is expected to decrease OCD-symptoms.

Registry
clinicaltrials.gov
Start Date
March 9, 2018
End Date
February 15, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Fabian Lenhard

PhD, Principal Investigator

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • a diagnosis of OCD according to DSM-5
  • a diagnosis of autism according to DSM-IV or DSM-5, confirmed with the Autism Diagnostic Interview- Revised or Autism Diagnostic Observation Schedule version 1 or 2 and by medical records
  • a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale
  • age between 7 and 17 years
  • ability to read and write Swedish
  • access to the internet
  • a parent that is able to co-participate in the treatment
  • participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment

Exclusion Criteria

  • a diagnosis of psychosis, bipolar disorder, severe eating disorder or intellectual disabilities
  • comorbid hoarding disorder or OCD with hoarding as a principal symptom.
  • suicidal ideation
  • subject not able to read or understand the basics of the ICBT material
  • completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
  • ongoing psychological treatment for OCD or any anxiety disorder
  • OCD treatment is not an immediate priority

Outcomes

Primary Outcomes

Children's Yale-Brown Obsessive Compulsive Scale

Time Frame: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

Changein obsessions and compulsions will be measured as the total score on the scale.. Total score ranges from 0 to 40 points, a higher score indicates more severe OCD. The scale is rated by a clinician.

Secondary Outcomes

  • Obsessive-compulsive inventory - child version(Baseline, weekly during treatment, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Education, work and social adjustment scale - child and parent version(Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Family accommodation scale for obsessive-compulsive disorder(Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Mood and Feeling Questionnaire - child and parent version(Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Mini International Neuropsychiatric Interview for Children and Adolescents(Baseline)
  • Children's global assessment scale(Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Clinical global impression - severity(Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Children's Assessment Scale for Developmental Disabilities(Baseline)
  • Autism spectrum quotient (AQ-10)(Baseline)
  • Children's Obsessional Compulsive Inventory Revised - parent rated (ChOCI-R-P)(Baseline, weekly during treatment, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Completed treatment modules(week 16)
  • Clinical global impression - improvement(16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment)
  • Client Satisfaction Questionnaire (CSQ-8)(16 weeks)
  • Parent strategies(Post-treatment)
  • Drop-out rate from treatment(at week 16)
  • internet intervention Patient Adherence Scale(8 weeks, 16 weeks)
  • Patient EX/RP Adherence Scale(Weekly for 16 weeks (during treatment))

Study Sites (1)

Loading locations...

Similar Trials